Hepatocellular carcinoma risk panel:-:Pt:Ser/Plas:-:

Preferred Label : Hepatocellular carcinoma risk panel:-:Pt:Ser/Plas:-:;

LOINC status : ACTIVE;

LOINC display name : Hepatocellular carcinoma risk panel;

LOINC long common name : Hepatocellular carcinoma risk panel - Serum or Plasma;

LOINC short name : Hep Ca Risk Pnl SerPl;

LOINC description : This assay includes a GALAD (gender, age, alpha-fetoprotein (AFP)-L3, AFP, des-gamma-carboxy prothrombin [DCP]) model score calculation to calculate the probability of hepatocellular carcinoma (HCC). The GALAD model is reported to be more accurate in diagnosing HCC compared to the use of the individual markers.;

Details

Origin ID

96452-8;

UMLS CUI

C5401205;

Has component
- Hepatocellular carcinoma risk [LOINC component]
- Hepatocellular carcinoma risk panel [LOINC component]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Panel of LOINC codes
- Acarboxyprothrombin:MCnc:Pt:Ser/Plas:Qn: [LOINC code]
- Age:Time:Pt:^Patient:Qn: [LOINC code]
- Alpha-1-Fetoprotein & Alpha-1-Fetoprotein.L3 panel:-:Pt:Ser/Plas:-: [LOINC code]
- Hepatocellular carcinoma risk:Score:Pt:^Patient:Qn:GALAD [LOINC code]
- Probability of developing disease assessed:Likelihood:Pt:^Patient:Qn: [LOINC code]
- Sex:Type:Pt:^Patient:Nom: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients